A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson

• Published in: Human vaccines & immunotherapeutics Vol. 18; no. 1; p. 2002083
• Main Authors: Patel, Rikin, Kaki, Mohamad, Potluri, Venkat S., Kahar, Payal, Khanna, Deepesh
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 31.12.2022; Taylor & Francis Group
• Subjects: coronavirus; Coronavirus – Review; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines; Humans; Johnson & Johnson; Moderna; Pandemics - prevention & control; Pfizer; Review; SARS-CoV-2; United States; Vaccination; Vaccine; United States; COVID-19; SARS-CoV-2; Johnson & Johnson; Pfizer; Moderna; coronavirus; Vaccine

The novel coronavirus outbreak was declared a pandemic in March 2020. We are reviewing the COVID-19 vaccines authorized for use in the United States by discussing the mechanisms of action, administration, side effects, and efficacy of vaccines developed by Pfizer, Moderna, and Johnson & Johnson....